NCT07302048Recruiting
Impact and Determinants of Success of a Mobile Multidisciplinary Intervention System Specialized in Pain Management for Patients With Moderate to Severe Intellectual Development Disorder, Isolated or Associated With an ASD or Multiple Disability
Impact and Determinants of Success of a Mobile Multidisciplinary Intervention System Specialized in Pain Management for Patients With Moderate to Severe Intellectual Development Disorder, Isolated or Associated With an ASD or Multiple Disability - MoDIDol
Source: ClinicalTrials.gov · Last updated 24 Dec 2025
Brief summary (registry, in English)
Pain is described by patients with a Neurodevelopmental Disorder (NDD), including Autism Spectrum Disorder (ASD), Intellectual Development Disorder (IDD) or multiple disabilities, and the family as one of the main associated disorders; its management is also one of the main concerns of families and professionals. At present, there is no validated and tested pain management system in populations facing complex pain situations. In response to the lack of a pain management services, a multi-disciplinary mobile team was set up in September 2022 at the Brest University Hospital (Mobile Pain Handicap Team Intellectual Disability 0-25 years; MoDIDol). This team offers a specific protocol for the assessment and management of pain that takes into account the social and family environment, the living context and the clinical characteristics of patients (children, adolescents and young adults (0-25 years) with IDD, ASD or multiple disabilities). The team includes at least one paediatrician specialising in the assessment and treatment of pain and a nurse, and travels to patients' usual living environments.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- First submitted
- 3 Jul 2025
- Start date
- 14 Oct 2025
- Primary completion date
- 20 Apr 2028
- Lead sponsor
- University Hospital, Brest
- Diseases
- Autism
- NCT number
- NCT07302048
What you commit to
- Study type: Interventional
- Planned participants: 80
- From 14 Oct 2025 to the primary completion date, 20 Apr 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- More than three places of residence and/or care settings
- Parents or legal guardians who do not have sufficient language or comprehension skills to provide informed consent or complete study questionnaires
Who the study is looking for
- Aged from birth up to 24 years inclusive (i.e., under 25 years old)
- Medical diagnosis of intellectual disability (ID), isolated or associated with autism spectrum disorder (ASD), developmental disorder (DD), or profound multiple disabilities, based on international classification systems (ICD-11 or DSM-5)
- Confirmed probable or definite pain diagnosis, as validated by the MoDIDol team
- PGIC score ≥ 3
- Living in or receiving care in the departments of Finistère, Côtes-d'Armor, or Morbihan
- Written informed consent provided by parents, legal guardians, or holders of parental authority, authorizing data collection for research and publication purposes
- Affiliated with or benefiting from a French national health insurance scheme
Age in the registry: - to 24 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU de Brest - Hôpital Morvan Coordinator of this site? Confirm its status | Brest | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.